AU728851B2 - Wound healing - Google Patents

Wound healing Download PDF

Info

Publication number
AU728851B2
AU728851B2 AU59953/98A AU5995398A AU728851B2 AU 728851 B2 AU728851 B2 AU 728851B2 AU 59953/98 A AU59953/98 A AU 59953/98A AU 5995398 A AU5995398 A AU 5995398A AU 728851 B2 AU728851 B2 AU 728851B2
Authority
AU
Australia
Prior art keywords
wound
lap
healing
use according
latency associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59953/98A
Other languages
English (en)
Other versions
AU5995398A (en
Inventor
Mark William James Ferguson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Victoria University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victoria University of Manchester filed Critical Victoria University of Manchester
Publication of AU5995398A publication Critical patent/AU5995398A/en
Application granted granted Critical
Publication of AU728851B2 publication Critical patent/AU728851B2/en
Assigned to RENOVO LIMITED reassignment RENOVO LIMITED Alteration of Name(s) of Applicant(s) under S113 Assignors: VICTORIA UNIVERSITY OF MANCHESTER, THE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
AU59953/98A 1997-02-13 1998-02-13 Wound healing Ceased AU728851B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9702943 1997-02-13
GBGB9702943.3A GB9702943D0 (en) 1997-02-13 1997-02-13 Wound healing
PCT/GB1998/000316 WO1998035695A1 (en) 1997-02-13 1998-02-13 Wound healing

Publications (2)

Publication Number Publication Date
AU5995398A AU5995398A (en) 1998-09-08
AU728851B2 true AU728851B2 (en) 2001-01-18

Family

ID=10807557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59953/98A Ceased AU728851B2 (en) 1997-02-13 1998-02-13 Wound healing

Country Status (12)

Country Link
US (1) US6319907B1 (enExample)
EP (1) EP1009425B1 (enExample)
JP (1) JP4307561B2 (enExample)
AT (1) ATE223228T1 (enExample)
AU (1) AU728851B2 (enExample)
CA (1) CA2280873C (enExample)
DE (1) DE69807710T2 (enExample)
DK (1) DK1009425T3 (enExample)
ES (1) ES2181165T3 (enExample)
GB (1) GB9702943D0 (enExample)
PT (1) PT1009425E (enExample)
WO (1) WO1998035695A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756060B1 (en) * 1996-09-19 2004-06-29 Usbiomaterials Corp. Anti-inflammatory and antimicrobial uses for bioactive glass compositions
EP1296704A4 (en) * 2000-06-14 2005-04-27 Chanda Bhuwalka Zaveri PEPTIDES WITH PHYSIOLOGICAL ACTIVITY
US20030148924A1 (en) * 2002-07-09 2003-08-07 Tamar Tennenbaum Methods and pharmaceutical compositions of healing wounds
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
US20100129332A1 (en) * 2000-07-31 2010-05-27 Tamar Tennenbaum Methods and pharmaceutical compositions for healing wounds
DK1383540T3 (da) * 2000-07-31 2009-08-24 Univ Bar Ilan Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
WO2005016254A2 (en) * 2003-07-16 2005-02-24 The Ohio State University Research Foundation Methods and reagents for treating inflammation and fibrosis
CA2535029C (en) * 2003-08-07 2013-07-16 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
US8367606B2 (en) * 2005-08-29 2013-02-05 Healor Ltd. Method and compositions for prevention and treatment of diabetic and aged skin
KR20150072458A (ko) 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. 상처 치유를 위한 개선 방법 및 조성물
NZ582556A (en) * 2007-07-30 2013-02-22 Healor Ltd Pharmaceutical composition for treating wounds and related methods
KR101668803B1 (ko) * 2007-10-29 2016-10-24 헬릭스 바이오메딕스, 인코포레이티드 보호용 피부 관리 테트라펩티드
AU2008343758A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
AU2008343843A1 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Improved medical devices
CA2710375A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Treatment of orthopedic conditions
US20100172217A1 (en) * 2009-01-08 2010-07-08 Von Bezold Ernst System of Methods and Apparati for Handling and Modifying Information Energy and Matter by Formative Resonance
KR20130095835A (ko) * 2009-02-24 2013-08-28 힐로 리미티드 여드름 및 기타 질환 치료용 비스파틴 치료제
EP2523677A2 (en) 2010-01-11 2012-11-21 Healor Ltd. Method for treatment of inflammatory disease and disorder
US9387183B2 (en) 2011-12-28 2016-07-12 Kuwait University Method of treating diabetes-related impaired wound healing
EP4491184A3 (en) 2014-08-22 2025-03-26 Auckland Uniservices Limited Channel modulators
US10232009B1 (en) * 2017-09-29 2019-03-19 Pro Sunfun Biotech Research And Development Co., Ltd. Peptide for promoting wound healing, its composition and method of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE131872T1 (de) * 1989-11-22 1996-01-15 Genentech Inc Latenz assoziierte peptide und deren verwendung
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
AU5587094A (en) 1992-10-26 1994-05-24 Kirin Brewery Company, Limited Method for producing large latent transforming growth factor-beta complexes and large latency associated peptide
US6074840A (en) * 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
JP4083794B2 (ja) * 1994-03-29 2008-04-30 レノボ・リミテッド 創傷の治癒

Also Published As

Publication number Publication date
WO1998035695A1 (en) 1998-08-20
PT1009425E (pt) 2002-11-29
CA2280873C (en) 2010-04-06
HK1025504A1 (en) 2000-11-17
DE69807710T2 (de) 2003-06-05
DE69807710D1 (de) 2002-10-10
JP2001511797A (ja) 2001-08-14
GB9702943D0 (en) 1997-04-02
AU5995398A (en) 1998-09-08
ATE223228T1 (de) 2002-09-15
EP1009425A1 (en) 2000-06-21
US6319907B1 (en) 2001-11-20
ES2181165T3 (es) 2003-02-16
EP1009425B1 (en) 2002-09-04
CA2280873A1 (en) 1998-08-20
JP4307561B2 (ja) 2009-08-05
DK1009425T3 (da) 2002-10-14

Similar Documents

Publication Publication Date Title
AU728851B2 (en) Wound healing
CA2105652C (en) Reducing wound scarring with antibodies to growth factors
US7572452B2 (en) Method for stimulating wound healing
EP0855916B1 (en) Pharmaceutical composition containing an activin stimulator
JP2003502350A (ja) 傷癒合促進用促進傷被覆材
AU2006268091C1 (en) Promotion of epithelial regeneration
WO1998036061A2 (en) Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity
US20110059896A1 (en) Use of furin convertase inhibitors in the treatment of fibrosis and scarring
US20020103112A1 (en) Wound healing and treatment of fibrosis
HK1025504B (en) Use of latency associated peptide for the manufacture of a medicament for increasing wound healing
JP2012012344A (ja) 創傷治癒剤
HK1025732B (en) Wound healing and treatment of fibrosis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC1 Assignment before grant (sect. 113)

Owner name: RENOVO LIMITED

Free format text: THE FORMER OWNER WAS: THE VICTORIA UNIVERSITY OF MANCHESTER